R. Gopalakrishnan et al., Matrix gamma-carboxyglutamic acid protein is a key regulator of PTH-mediated inhibition of mineralization in MC3T3-E1 osteoblast-like cells, ENDOCRINOL, 142(10), 2001, pp. 4379-4388
As part of its overall function as a major regulator of calcium homeostasis
, PTH stimulates bone resorption and inhibits osteoblast-mediated biominera
lization. To determine the basis for the inhibitory actions of this hormone
, we compared the time course of PTH-dependent inhibition of mineralization
in MC3T3-E1 osteoblast-like cells with changes in mRNA levels for several
extracellular matrix proteins previously associated either with induction o
r inhibition of mineralization. Mineralizing activity was rapidly lost in P
TH-treated cells (similar to 30% inhibition after 3 h, 50% inhibition at 6
h). Of the proteins examined, changes in matrix gamma -carboxyglutamic acid
protein were best correlated with PTH-dependent inhibition of mineralizati
on. Matrix gamma -carboxyglutamic acid protein mRNA was rapidly induced 3 h
after PTH treatment, with a 6- to S-fold induction seen after 6 h. Local i
n vivo injection of PTH over the calvaria of mice also induced a 2-fold inc
rease in matrix gamma -carboxyglutamic acid protein mRNA. Warfarin, an inhi
bitor of matrix gamma -carboxyglutamic acid protein gamma -carboxylation, r
eversed the effects of PTH on mineralization in MC3T3-E1 cells, whereas vit
amin K enhanced PTH activity, as would be expected if a gamma -carboxygluta
mic acid-containing protein were required for PTH activity. Levels of the o
ther mRNAs examined were not well correlated with the observed changes in m
ineralization. Osteopontin, an in vitro inhibitor of mineralization, was in
duced approximately 4-fold 12 h after PTH addition. Bone sialoprotein mRNA,
which encodes an extracellular matrix component most frequently associated
with mineral induction, was inhibited by 50% after 12 h of PTH treatment.
Osteocalcin mRNA, encoding the other known gamma -carboxyglutamic acid prot
ein in bone, was also inhibited by PTH, but, again, with a significantly sl
ower time course than was seen for mineral inhibition. Taken together, thes
e results show that the rapid inhibition of osteoblast mineralization induc
ed by in vitro PTH treatment is at least in part explained by induction of
matrix gamma -carboxyglutamic acid protein.